Scarica l'app Stockscreener
0.6109
15.46%
+0.0818
Pre-mercato:
.63
0.0191
+3.13%
Precedente Chiudi:
$0.5291
Aprire:
$0.54
Volume 24 ore:
6.60M
Capitalizzazione di mercato:
$295.01M
Reddito:
$247.99M
Utile/perdita netta:
$-521.97M
Rapporto P/E:
-0.8485
EPS:
-0.72
Flusso di cassa netto:
$-194.28M
1 W Prestazione:
+22.77%
1M Prestazione:
+37.84%
6M Prestazione:
-27.37%
1 anno Prestazione:
-69.76%
Intervallo 1D:
$0.5305
$0.6198
Portata 52W:
$0.35
$2.20
23andMe Holding Co Stock (ME) Company Profile
Nome
23andMe Holding Co
Settore
Industria
Telefono
650 938 6300
Indirizzo
223 North Mathilda Avenue, Sunnyvale
23andMe Holding Co Stock (ME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-09-22 | Iniziato | Cowen | Outperform |
| 2021-11-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-07-12 | Iniziato | Citigroup | Buy |
23andMe Holding Co Borsa (ME) Ultime notizie
23andMe to Report Q4 and Full Year FY2024 Financial Results
GlobeNewswire Inc.
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire Inc.
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
The Motley Fool
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
GlobeNewswire Inc.
Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
The Motley Fool
23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
GlobeNewswire Inc.
23andMe Holding Co Azioni (ME) Dati Finanziari
23andMe Holding Co (ME) Reddito 2024
ME ha riportato un ricavo (TTM) di $247.99 milioni per il trimestre terminato il 2023-12-31, un -19.40% declino anno su anno.
23andMe Holding Co (ME) Reddito netto 2024
ME l'utile netto (TTM) è stato di -$521.97 milioni per il trimestre terminato il 2023-12-31, un -64.61% diminuire anno su anno.
23andMe Holding Co (ME) Flusso di cassa 2024
ME ha registrato un flusso di cassa disponibile (TTM) di -$194.28 milioni per il trimestre conclusosi con 2023-12-31, un -16.44% diminuire anno su anno.
23andMe Holding Co (ME) Utile per azione 2024
L'utile per azione (TTM) di ME è stato pari a -$1.11 per il trimestre terminato il 2023-12-31, un -56.34% declino anno su anno.
23andMe Holding Co Azioni (ME) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HIBBS KATHY L | Chief Administrative Officer |
May 02 '24 |
Sale |
0.49 |
38,551 |
19,048 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 18 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 18 '24 |
Sale |
0.47 |
38,548 |
18,148 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 04 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Apr 04 '24 |
Sale |
0.50 |
38,548 |
19,282 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 21 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 21 '24 |
Sale |
0.46 |
38,548 |
17,894 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 07 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,290,863 |
| HIBBS KATHY L | Chief Administrative Officer |
Mar 07 '24 |
Sale |
0.53 |
38,548 |
20,430 |
1,252,315 |
| HIBBS KATHY L | Chief Administrative Officer |
Feb 22 '24 |
Option Exercise |
0.42 |
38,548 |
16,190 |
1,278,375 |
0.39%
Capitalizzazione:
|
Volume (24 ore):